| Particulars |
|
|
|
| Company Name
| Fredun Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
16.54 |
B.V. (₹) |
163.10 |
| Sales(₹ Cr.) |
635.47 |
NP (₹ Cr.) |
33.21 |
| NP Var% |
60.00 |
Div% |
7.00 |
| CPS(₹) |
24.90 |
EPS (₹) |
20.10 |
| Traded Value(₹ Lakhs) |
584.92 |
52 Week High |
1,600.00 |
| 52 Week Low |
343.00 |
Price BSE |
1,453.00 |
| Price NSE |
1,474.00 |
Market Capital (₹ Cr.) |
2,403.56 |
| P/C Ratio |
58.40 |
P/E Ratio |
72.40 |
| Price Vs.BV |
8.91 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
227.76 |
| NP(₹ Cr.) |
13.17 |
NP Var % |
95.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
388.30 |
| OPM |
11.88 |
NP |
17.69 |
| NP Var% |
89.58 |
EPS |
26.87 |
| PE |
54.09 |
|
|